Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitória, Brazil

BackgroundDengue is caused by a RNA virus of the family Flaviviridae, which presents four serotypes (DENV-1 to DENV-4) capable of inducing hemorrhage. The purpose of this study was to evaluate the influence of serotype on the outcome of dengue.MethodsThis cross-sectional study included data from dengue cases with serotyping results that occurred between 2009 and 2013 in Vitória, Espírito Santo, Brazil. Data were accessed through the Information System for Notifiable Diseases. Chi-square test, Fisher exact test, Mann–Whitney U test, and logistic regression were performed to assess associations between different serotypes and dengue severity, while considering gender and age.ResultsThe sample consisted of 485 laboratory confirmed dengue cases, of which 46.4 % were females, with median age of 26 years. Regarding overall samples, 77.3 % were caused by DENV-1, 16.1 % by DENV-4, 6.4 % by DENV-2, and 0.2 % by DENV-3. Severe dengue affected 6.6 % of all cases, of which 32.3 % of the cases caused by DENV-2, 6.4 % of those caused by DENV-4, 4.5 % of those caused by DENV-1, and none of those caused by DENV-3. Severe dengue was found to be seven times more frequent among cases of DENV-2 than among those of the other serotypes.ConclusionsThe present study found that cases of DENV-2 had a higher proportion of severe dengue than among those of DENV-1 and DENV-4. Consequently, early detection of serotypes circulating in the territory could be an important approach to prevent increasing numbers of severe outcomes during dengue outbreaks by predicting the health support needed for early diagnoses and treatment of dengue cases.

[1]  T. Hien,et al.  Factors Associated with Dengue Shock Syndrome: A Systematic Review and Meta-Analysis , 2013, PLoS neglected tropical diseases.

[2]  Donald S Burke,et al.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. , 2003, The American journal of tropical medicine and hygiene.

[3]  R. Rico-Hesse Microevolution and virulence of dengue viruses. , 2003, Advances in virus research.

[4]  D. Gubler,et al.  Viraemia in patients with naturally acquired dengue infection. , 1981, Bulletin of the World Health Organization.

[5]  E. Chungue,et al.  Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory‐confirmed cases , 1999, Tropical medicine & international health : TM & IH.

[6]  Alan L Rothman,et al.  Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. , 2002, American journal of epidemiology.

[7]  M. Guzmán,et al.  Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  R. Césaire,et al.  Clinical presentation of dengue by serotype and year of epidemic in Martinique. , 2014, The American journal of tropical medicine and hygiene.

[9]  C. King,et al.  Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Pham Thi Thao Khuong,et al.  Immunological and Viral Determinants of Dengue Severity in Hospitalized Adults in Ha Noi, Viet Nam , 2011, PLoS neglected tropical diseases.

[11]  I. Louro,et al.  Phylogenetic characterization of dengue virus type 2 in Espírito Santo, Brazil , 2011, Molecular Biology Reports.

[12]  J. Meynard,et al.  Clinical and Virological Study of Dengue Cases and the Members of Their Households: The Multinational DENFRAME Project , 2012, PLoS neglected tropical diseases.

[13]  M. Bangs,et al.  Epidemic dengue transmission in southern Sumatra, Indonesia. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  Derek A. T. Cummings,et al.  Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006 , 2010, PLoS neglected tropical diseases.

[15]  R. Kumaria Correlation of disease spectrum among four Dengue serotypes: a five years hospital based study from India. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[16]  R. Medronho,et al.  [Clinical differences observed in patients with dengue caused by different serotypes in the epidemic of 2001/2002, occurred in Rio de Janeiro]. , 2004, Revista da Sociedade Brasileira de Medicina Tropical.

[17]  E. Harris,et al.  Serotype-specific differences in clinical manifestations of dengue. , 2006, The American journal of tropical medicine and hygiene.

[18]  S. Kalayanarooj,et al.  Clinical and Laboratory Presentations of Dengue Patients with Different Serotypes , 2000 .

[19]  Y. Poovorawan,et al.  Changing Pattern of Dengue Virus Serotypes in Thailand between 2004 and 2010 , 2012, Journal of health, population, and nutrition.

[20]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[21]  Fatiha Najioullah,et al.  Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. , 2008, The American journal of tropical medicine and hygiene.

[22]  C. King,et al.  High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. , 2003, Virology.

[23]  M. Guzmán,et al.  Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. , 1990, The American journal of tropical medicine and hygiene.

[24]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.

[25]  R. Rico-Hesse,et al.  Dengue Virus Structural Differences That Correlate with Pathogenesis , 1999, Journal of Virology.

[26]  G. Áñez,et al.  Differential Oxidative Stress Induced by Dengue Virus in Monocytes from Human Neonates, Adult and Elderly Individuals , 2013, PloS one.

[27]  K. Abromeit Music Received , 2023, Notes.

[28]  G. Kuno,et al.  Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. , 1984, The American journal of tropical medicine and hygiene.

[29]  G. Evans Lessons and Challenges , 2011 .

[30]  B. D. Saúde. Dengue: diagnóstico e manejo clínico: adulto e criança , 2005 .

[31]  E. Gotuzzo,et al.  Correlation of Serotype-Specific Dengue Virus Infection with Clinical Manifestations , 2012, PLoS neglected tropical diseases.

[32]  Y. Leo,et al.  Dengue Serotype-Specific Differences in Clinical Manifestation, Laboratory Parameters and Risk of Severe Disease in Adults, Singapore , 2015, The American journal of tropical medicine and hygiene.

[33]  G. Carrasquilla,et al.  Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.

[34]  R. Lanciotti,et al.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.